We are monitoring the impact of COVID-19 on Hormone Replacement Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 896
Share on
Share on

Global Hormone Replacement Therapy Market Analysis Report - Segmented By Type (Estrogen Replacement Therapy, Growth Hormone Replacement Therapy and Thyroid Replacement Therapy), By Route of Administration (Oral, Parenteral, Transdermal and Other Routes) & By Region - Industry Size, Share, Trends, Growth, Forecast | 2019 – 2024

Pulished: February, 2020
ID: 896
Pages: 185

Global Hormone Replacement Therapy Market Size & Growth (2019-2024)

As per our report, the size of the global hormone replacement therapy market was worth USD 15.75 billion in 2019 and to grow USD 22.31 billion by 2024, showcasing a CAGR of 7.21% during the forecast period.

This hormonal replacement therapy is a medical term used for substituting the natural hormones that are present in the human body with other hormones.

Industry Analysis

In general, this hormonal replacement takes place in females, especially those who are in menopause stage, which is for restoring the hormones. This HRT used for diseases like cancer, arthritis and also rise in novel drug development. Hormones like estrogen, testosterone and follicle-stimulating hormone are the hormones that can help in the replacement therapy of hormones.

As the elderly population grows, hormonal imbalance is one of the main factors driving the growth of the market. Due to various hormonal changes, the female body is primarily affected by the natural ageing process, leading to abnormalities and illness. Some common problems include weight gain, memory loss, fatigue, decreased libido, the appearance of ageing and loss of muscle.

Drivers & Restrains

The increase in demand for advance medical solutions and changes made in the new lifestyle is boosting up the market growth of HRT. The support that women get from government increases the HRT market growth. Customary approvals like the FDA by introducing different kinds of initiatives for the help of women's health. Increasing knowledge among the women about the HRT also boost up the market. Additionally, factors that have a positive effect on market growth include increased women's awareness of postmenopausal issues, increased drug development due to new drug delivery systems, and an increasing elderly population that leads to hormonal disorders.

Profitable and non-profitable organizations spread awareness by offering treatments of low-cost for low and middle-income people. Increase in elder people population, increase in novel drug development and hormonal disorders also increase the market. The advantages that are related to the HRT that comprises of minimum occurrences of heart diseases, osteoporosis and blood vessels symptoms are fuelling the market growth.

Hormonal replacement therapy shows harmful effects like swelling, bloating, nausea, headache etc. and this attribute hampers the market growth. This replacement may not be appropriate for the patients, who have a past medical history like blood clots, liver disease and patients with high blood pressure. It may also degrade the demand of the market. However, the high cost that is associated with the replacement therapy is restraining the market.

The high cost of these therapies, some side effects, and product shortages due to weak pipelines are some of the factors that are supposed to hinder business growth.

Recent Market Developments

  • On December 17, 2019, Pfizer, Inc. has introduced a new drug known as Xtandi, which has received an acceptance from U.S. FDA.  This Xtandi is a combination with anti-hormone therapy and helps in reduction of cancer spreading.
  • On May 09, 2007, Wyeth’s new drug Pristiq suffering with the symptoms of menopause like hot flashes without an important impact. This has been approved by the U.S. FDA for the treatment and this one of the hormone replacement therapy.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2018-2024

Base Year

2018

Forecast Period

2019-2024

Segments Covered

By Type, Basis of Route of Administration and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the Global Hormone Replacement Therapy Market has been segmented and sub-segmented into the following categories and calculated market size and forecast for each segment until 2024.

Hormone Replacement Therapy Market - By Type

  • Estrogen Replacement Therapy
  • Growth Hormone Replacement Therapy
  • Thyroid Replacement Therapy

Based on type, with a market share of more than 60%, the estrogen replacement therapy segment dominates the market. The Estrogen Replacement Therapy is accounted for more than 50% of the share market. This replacement therapy in which estrogen hormones are commonly used to treat the symptoms seen in women for menopause. This helps to decrease short-term changes of menopause like vaginal dryness, hot flashes and disturbed sleep in women.

Hormone Replacement Therapy Market - By Route of Administration

  • Oral
  • Parenteral
  • Transdermal
  • Other Routes

Based on the route of administration, the oral route of administration segment is regarded to be one of the safest and most preferred routes of drug administration. The Oral Route of Administration segment is accounted for the highest share market.  This oral segment is a sub-division of enteral administration.

Regional Analysis

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa

Of these five regions, North America region is likely to dominate the market and this region is expected to maintain its power and influence during the period. This is due to the factors like new methods or products in drug delivering systems, developing new drugs and increase in people population target in this region. Also, increase in common menopause disorders and also rising occurrences of hormone deficiency disorders and also, the awareness among the people related to these therapies is also one of the factors that drive the market.

Asia-Pacific is likely to have highest growth rate in the upcoming years due to the factors like people having awareness about the hormone replacement therapy and in this region countries like China, India and Japan, these countries are expected to have high growth rate during the period.

The Middle East and Africa is likely to have moderate demand due to increasing occurrences of chronic diseases like cancer that require hormone replacement therapy.

North America dominated the market, where the majority of the contribution was from the USA while the market in the APAC region is to witness rapid growth during the forecast period.

Key companies dominating the Global Hormone Replacement Therapy Market profiled in the report are

  • Abbott Laboratories
  • Novartis
  • Pfizer
  • Mylan Laboratories
  • Amgen
  • Merck & Co
  • Bayer
  • Eli Lily
  • Novo Nordisk
  • Wyeth
  • F. Hoffmann-La Roche
  • Hisamitsu Pharmaceutical Co. Inc.

Leading companies are focusing on collaborations and mergers, which are anticipated over the next seven years to share the cost of technology and innovation in this area. 

Pfizer completed the Weiss merger in December 2014, outpacing popular products such as Prempro and Premarin.

1.Introduction       

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods

                1.4 General Study Assumptions                                

2. Research Methodology                

                2.1 Introduction   

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview           

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                   

                 5.1 By Hormone Type                                   

                                5.1.1 Estrogen Replacement Therapy                     

                                5.1.2 Growth Hormone Replacement Therapy                   

                                5.1.3 Thyroid Replacement Therapy                       

                                5.1.4 Others                      

                5.2 By Route of Administration                                 

                                5.2.1 Oral                            

                                5.2.2 Parenteral               

                                5.2.3 Transdermal                           

                                5.2.4 Others                      

6. Geographical Analysis                   

                6.1 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.2 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                           

                                6.2.6 France                      

                6.3 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                        

                                6.3.5 South Korea                           

                                6.3.6 Australia                  

                6.4 Latin America 

                                6.4.1 Introduction                           

                                6.4.2 Brazil                         

                                6.4.3 Argentina                

                                6.4.4 Mexico                     

                6.5 Middle East & Africa                               

                                6.5.1 Introduction                           

                                6.5.2 Middle-East                            

                                6.5.3 Africa                        

7. Pipeline Product Analysis            

                7.1 Overview         

                7.2 Pipeline Development Landscape         

                7.3 Molecular Targets in the Pipeline          

                7.4 Clinical Trials  

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target                       

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target                                  

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.                               

8.Strategic Analysis             

                8.1 PESTLE analysis                                         

                                8.1.1 Political                     

                                8.1.2 Economic                 

                                8.1.3 Social                         

                                8.1.4 Technological                         

                                8.1.5 Legal                          

                                8.1.6 Environmental                      

                8.2 Porter’s Five analysis   

                                8.2.1 Bargaining Power of Suppliers                        

                                8.2.2 Bargaining Power of Consumers                    

                                8.2.3 Threat of New Entrants                     

                                8.2.4 Threat of Substitute Products and Services               

                                8.2.5 Competitive Rivalry within the Industry                      

9.Market Leaders' Analysis               

                9.1 Abbott Laboratories                               

                                9.1.1 Overview                

                                9.1.2 Product Analysis                   

                                9.1.3 Financial analysis                  

                                9.1.4 Recent Developments                       

                                9.1.5 SWOT analysis                       

                                9.1.6 Analyst View                          

                9.2 Novartis                                       

                9.3 Pfizer 

                9.4 Mylan Laboratories                                 

                9.5 Amgen                                         

                9.6 Merck & Co.                               

                9.7 Bayer 

                9.8 Eli Lily & Company                                  

                9.9 Novo Nordisk 

                9.10 Wyeth                                        

                9.11 F. Hoffmann-La Roche                                         

                9.12 Hisamitsu Pharmaceutical  Co. Inc.                                 

10.Competitive Landscape               

                10.1 Market share analysis                                          

                10.2 Merger and Acquisition Analysis                                     

                10.3 Agreements, collaborations and Joint Ventures                                       

                10.4 New Product Launches                                       

11.Expert Opinions              

                11.1 Market Outlook                                     

                11.2 Investment Opportunities                                 

Appendix                

                a) List of Tables                                

                b) List of Figures   

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  2. Global Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  3. Global Estrogen Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  4. Global Growth Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  5. Global Thyroid Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  6. Global Other Hormone Therapies Market By Region, From 2019-2024 (USD Million)
  7. Global Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  8. North America Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  9. North America Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  10. North America Estrogen Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  11. North America Growth Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  12. North America Thyroid Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  13. North America Other Hormone Therapies Market By Region, From 2019-2024 (USD Million)
  14. North America Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  15. United States Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  16. United States Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  17. Canada Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  18. Canada Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  19. Europe Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  20. Europe Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  21. Europe Estrogen Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  22. Europe Growth Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  23. Europe Thyroid Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  24. Europe Other Hormone Therapies Market By Region, From 2019-2024 (USD Million)
  25. Europe Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  26. United Kingdom Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  27. United Kingdom Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  28. Spain Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  29. Spain Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  30. Germany Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  31. Germany Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  32. France Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  33. France Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  34. Italy Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  35. Italy Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  36. Asia-Pacific Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  37. Asia-Pacific Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  38. Asia-Pacific Estrogen Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  39. Asia-Pacific Growth Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  40. Asia-Pacific Thyroid Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  41. Asia-Pacific Other Hormone Therapies Market By Region, From 2019-2024 (USD Million)
  42. India Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  43. India Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  44. China Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  45. China Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  46. Japan Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  47. Japan Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  48. South Korea Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  49. South Korea Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  50. Australia Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  51. Australia Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  52. Latin America Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  53. Latin America Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  54. Latin America Estrogen Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  55. Latin America Growth Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  56. Latin America Thyroid Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  57. Latin America Other Hormone Therapies Market By Region, From 2019-2024 (USD Million)
  58. Argentina Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  59. Argentina Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  60. Brazil Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  61. Brazil Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  62. Mexico Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  63. Mexico Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  64. Middle East & Africa Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  65. Middle East & Africa Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  66. Middle East & Africa Estrogen Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  67. Middle East & Africa Growth Hormone Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  68. Middle East & Africa Thyroid Replacement Therapy Market By Region, From 2019-2024 (USD Million)
  69. Middle East & Africa Other Hormone Therapies Market By Region, From 2019-2024 (USD Million)
  70. Middle East Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  71. Middle East Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)
  72. Africa Hormone Replacement Therapy Market By Hormone Type, From 2019-2024 (USD Million)
  73. Africa Hormone Replacement Therapy Market By Route of Administration, From 2019-2024 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample